Matthew Maxwell Donley - Net Worth and Insider Trading
Matthew Maxwell Donley Net Worth
The estimated net worth of Matthew Maxwell Donley is at least $5 Million dollars as of 2024-11-29. Matthew Maxwell Donley is the EVP, Ops & Strategy of Aurinia Pharmaceuticals Inc and owns about 584,072 shares of Aurinia Pharmaceuticals Inc (AUPH) stock worth over $5 Million. Details can be seen in Matthew Maxwell Donley's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthew Maxwell Donley has not made any transactions after 2024-03-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Matthew Maxwell Donley
Matthew Maxwell Donley Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew Maxwell Donley owns 1 companies in total, including Aurinia Pharmaceuticals Inc (AUPH) .
Click here to see the complete history of Matthew Maxwell Donley’s form 4 insider trades.
Insider Ownership Summary of Matthew Maxwell Donley
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc | 2024-03-06 | Ex VP & Intern'l Operations |
Matthew Maxwell Donley Latest Holdings Summary
Matthew Maxwell Donley currently owns a total of 1 stock. Matthew Maxwell Donley owns 584,072 shares of Aurinia Pharmaceuticals Inc (AUPH) as of March 6, 2024, with a value of $5 Million.
Latest Holdings of Matthew Maxwell Donley
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc | 2024-03-06 | 584,072 | 8.85 | 5,169,037 |
Holding Weightings of Matthew Maxwell Donley
Matthew Maxwell Donley Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew Maxwell Donley has made a total of 3 transactions in Aurinia Pharmaceuticals Inc (AUPH) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in Aurinia Pharmaceuticals Inc is the sale of 40,665 shares on March 6, 2024, which brought Matthew Maxwell Donley around $224,064.
Insider Trading History of Matthew Maxwell Donley
- 1
Matthew Maxwell Donley Trading Performance
GuruFocus tracks the stock performance after each of Matthew Maxwell Donley's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Matthew Maxwell Donley is 67.67%. GuruFocus also compares Matthew Maxwell Donley's trading performance to market benchmark return within the same time period. The performance of stocks bought by Matthew Maxwell Donley within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Matthew Maxwell Donley's insider trading performs compared to the benchmark.
Performance of Matthew Maxwell Donley
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.86 | | | | | |
| Relative Return to S&P 500(%) | 0.95 | | | | | |
Matthew Maxwell Donley Ownership Network
Matthew Maxwell Donley Owned Company Details
What does Aurinia Pharmaceuticals Inc do?
Who are the key executives at Aurinia Pharmaceuticals Inc?
Matthew Maxwell Donley is the Ex VP & Intern'l Operations of Aurinia Pharmaceuticals Inc. Other key executives at Aurinia Pharmaceuticals Inc include Chief Commercial Officer Scott Michael Habig , director & Chief Executive Officer Peter Greenleaf , and Chief Financial Officer Joseph M Miller .
Aurinia Pharmaceuticals Inc (AUPH) Insider Trades Summary
Over the past 18 months, Matthew Maxwell Donley made 1 insider transaction in Aurinia Pharmaceuticals Inc (AUPH) with a net sale of 40,665. Other recent insider transactions involving Aurinia Pharmaceuticals Inc (AUPH) include a net sale of 51,893 shares made by Scott Michael Habig , a net sale of 30,076 shares made by Volker Knappertz , and a net sale of 126,981 shares made by Peter Greenleaf .
In summary, during the past 3 months, insiders sold 9,798 shares of Aurinia Pharmaceuticals Inc (AUPH) in total and bought 0 shares, with a net sale of 9,798 shares. During the past 18 months, 373,927 shares of Aurinia Pharmaceuticals Inc (AUPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 373,927 shares.
Aurinia Pharmaceuticals Inc (AUPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aurinia Pharmaceuticals Inc Insider Transactions
Matthew Maxwell Donley Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew Maxwell Donley. You might contact Matthew Maxwell Donley via mailing address: 4520 East West Highway, 3rd Floor, Bethesda Md 20814.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
